ATE367150T1 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
ATE367150T1
ATE367150T1 AT97946111T AT97946111T ATE367150T1 AT E367150 T1 ATE367150 T1 AT E367150T1 AT 97946111 T AT97946111 T AT 97946111T AT 97946111 T AT97946111 T AT 97946111T AT E367150 T1 ATE367150 T1 AT E367150T1
Authority
AT
Austria
Prior art keywords
drug
Prior art date
Application number
AT97946111T
Other languages
English (en)
Inventor
Takehisa Hata
Yuji Tokunaga
Fumio Shimojo
Sumihisa Kimura
Takeo Hirose
Satoshi Ueda
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ATE367150T1 publication Critical patent/ATE367150T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97946111T 1996-12-06 1997-12-05 Arzneimittel ATE367150T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32661896 1996-12-06

Publications (1)

Publication Number Publication Date
ATE367150T1 true ATE367150T1 (de) 2007-08-15

Family

ID=18189823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97946111T ATE367150T1 (de) 1996-12-06 1997-12-05 Arzneimittel

Country Status (17)

Country Link
US (1) US6346537B1 (de)
EP (1) EP0943327B1 (de)
JP (1) JP4284706B2 (de)
KR (1) KR20000057242A (de)
CN (1) CN1149979C (de)
AR (1) AR008927A1 (de)
AT (1) ATE367150T1 (de)
AU (1) AU726451B2 (de)
BR (1) BR9713866A (de)
CA (1) CA2274485C (de)
DE (1) DE69737936T2 (de)
ES (1) ES2286835T3 (de)
HU (1) HU228680B1 (de)
RU (1) RU2197226C2 (de)
TW (1) TW426516B (de)
WO (1) WO1998024418A1 (de)
ZA (1) ZA9710927B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100440553B1 (ko) 1998-03-26 2004-07-15 후지사와 야꾸힝 고교 가부시키가이샤 서방성 제제
FR2781373B1 (fr) * 1998-07-07 2001-09-21 Pf Medicament Formulations thixotropes pour le remplissage de gelules
WO2000053177A1 (fr) 1999-03-11 2000-09-14 Fujisawa Pharmaceutical Co., Ltd. Preparations liposomiques
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
AUPR529701A0 (en) * 2001-05-28 2001-06-21 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
MXPA04007438A (es) 2002-02-01 2004-10-11 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
PT1517682E (pt) * 2002-06-28 2007-02-28 Speedel Pharma Ag Formulação farmacêutica compreendendo inibidor da renina não-peptídico e tensioactivo
CN1819817A (zh) * 2003-07-09 2006-08-16 株式会社钟根堂 一种泰克利玛的固体分散体
EP1653927B1 (de) 2003-08-04 2012-01-11 Bend Research, Inc. Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien
CN1859909B (zh) * 2003-08-29 2011-04-06 生命周期药物公司 含有他克莫司的固态分散体
PL1663216T3 (pl) 2003-08-29 2012-03-30 Veloxis Pharmaceuticals As Kompozycje o zmodyfikowanym uwalnianiu zawierające takrolimus
KR100866728B1 (ko) * 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
US7652364B2 (en) * 2005-12-21 2010-01-26 Teradata Us, Inc. Crossing conductive traces in a PCB
GB0602632D0 (en) * 2006-02-08 2006-03-22 Pliva Istrazivacki Inst D O O Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus
EP1923053A1 (de) * 2006-09-27 2008-05-21 Novartis AG Pharmazeutische Zusammensetzung umfassend Nilotinib oder dessen Salz
EP2124898B1 (de) * 2007-01-10 2013-08-14 Board of Regents, The University of Texas System Verstärkte freisetzung immunsuppressiver arzneizusammensetzungen zur pulmonalen verabreichung
KR100868295B1 (ko) * 2007-02-15 2008-11-11 풍림무약주식회사 레플루노미드를 함유하는 고체분산체 및 이의 제조방법
DK2167033T3 (en) 2007-05-30 2017-08-14 Veloxis Pharmaceuticals As Once daily oral dosage form comprising tacrolism
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
US8222272B2 (en) 2008-04-11 2012-07-17 Roxane Laboratories, Inc. Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
CN101580535B (zh) * 2008-05-16 2012-10-03 太景生物科技股份有限公司 丙型肝炎病毒蛋白酶抑制剂
RU2574006C2 (ru) * 2008-07-08 2016-01-27 Лайфсайкл Фарма А/С Такролимус для улучшенного лечения пациентов с трансплантатами
CN102149715A (zh) * 2008-09-17 2011-08-10 Cj第一制糖株式会社 肝适能的稳定化固态分散物及其制备方法
WO2011100975A2 (en) 2010-02-17 2011-08-25 Lifecycle Pharma A/S Stabilized tacrolimus composition
WO2011116034A1 (en) * 2010-03-17 2011-09-22 Lutran Industries, Inc. Human medicinal treatment and product typically based on salt of peroxymonosulfuric acid, and associated product fabrication
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
US9168246B2 (en) 2013-06-27 2015-10-27 Veloxis Pharmaceutical A/S Regimen for suppressing organ rejection
CN105663092A (zh) * 2016-03-03 2016-06-15 海南华益泰康药业有限公司 一种含有他克莫司固体分散体的缓释胶囊及其制备方法
EP3463369A4 (de) * 2016-05-26 2019-12-11 Dermala Inc. Zusammensetzungen und verfahren zur behandlung von akne vulgaris

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608080D0 (en) 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DK0406791T3 (da) 1989-07-05 1995-03-27 Fujisawa Pharmaceutical Co Vandigt flydende præparat til ekstern anvendelse
US5215995A (en) 1989-10-16 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Hair revitalizing agent
KR0177158B1 (ko) * 1990-03-01 1999-03-20 후지사와 도모기찌로 면역억제 활성을 갖는 트리사이클릭 화합물 함유 용액 제제
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
US5817333A (en) 1991-10-31 1998-10-06 Fujisawa Pharmaceutical Co., Ltd. Liposome preparation containing a tricyclic compound
ATE183083T1 (de) 1992-11-18 1999-08-15 Fujisawa Pharmaceutical Co Pharmazeutische zubereitung mit verlängerter wirkung
JPH07291854A (ja) * 1994-04-26 1995-11-07 Tanabe Seiyaku Co Ltd 溶解性の改善された医薬品製剤
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees

Also Published As

Publication number Publication date
DE69737936D1 (de) 2007-08-30
RU2197226C2 (ru) 2003-01-27
ZA9710927B (en) 1998-06-15
KR20000057242A (ko) 2000-09-15
US6346537B1 (en) 2002-02-12
AU5136998A (en) 1998-06-29
EP0943327A1 (de) 1999-09-22
EP0943327B1 (de) 2007-07-18
JP4284706B2 (ja) 2009-06-24
HU228680B1 (en) 2013-05-28
AR008927A1 (es) 2000-02-23
AU726451B2 (en) 2000-11-09
CA2274485A1 (en) 1998-06-11
WO1998024418A1 (fr) 1998-06-11
TW426516B (en) 2001-03-21
DE69737936T2 (de) 2007-12-06
CN1245424A (zh) 2000-02-23
CA2274485C (en) 2008-02-05
ES2286835T3 (es) 2007-12-01
BR9713866A (pt) 2000-03-14
HUP0000587A1 (hu) 2000-09-28
HUP0000587A3 (en) 2001-12-28
CN1149979C (zh) 2004-05-19
EP0943327A4 (de) 2003-06-25

Similar Documents

Publication Publication Date Title
DE69737936D1 (de) Arzneimittel
ATE187063T1 (de) Arzneimittel
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
ID23874A (id) Obat
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE69735712D1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
NO981946D0 (no) Imidazoquinazolin-derivater
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
ID16781A (id) Formulasi-formulasi farmasi
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
ID18698A (id) Komposisi farmasi
EE9800209A (et) Antiglükokortikoidne ravimaine
ITMI962628A0 (it) Composizione farmaceutica
DE29621865U1 (de) Portions-Tablette
DE59805373D1 (de) Nephroprotektive Arzneimittel
NO992244D0 (no) AIDS-legemiddel
DE29618094U1 (de) Pharmazeutisches Präparat
SE9602895D0 (sv) Intag av mediciner
SE9402131D0 (sv) Läkemedel
NO944330D0 (no) Legemiddel
SE9401674L (sv) Läkemedel
KR970004096U (ko) 약품진열장
SE9600141D0 (sv) Pharmaceutical formulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties